Study Supports Controversial Heart Failure Drug

Related Encyclopedia • Alzheimer's Disease • Aneurysms • Angina Pectoris • Angiogram More... Related Healthscout Videos Importance of Good Nutrition Controlling Incontinence Preventing Heart Disease the Easy Way Lifestyle Changes for Heart Disease Prevention and Treatment More... Related Animations • Alzheimer's Disease Video Animation • Angioplasty • Coronary Bypass Surgery • Erectile Dysfunction More... Related Drug Information • Accupril • Actonel • Altace • Avapro More... Related News Articles • Memory Lapses Come When 2 Parts of Brain Compete • Even Mild Sleep Apnea Hikes Heart Risk • 40 Years of Heart Transplants • Study Sheds New Light on Lung Cancer More...

Page:  << Prev | 1 | 2 | 3 | 4

Because of its small size and short follow-up, the Stanford study also failed to address the most important question of all: Does Natrecor increase patients' risk for death?

"Certainly this trial does not even attempt to answer mortality questions," Witteles agreed.

Those questions may only be answered by the large, prospective trial currently under development. "I think that that is the trial that will settle the matter," Sackner-Bernstein said. "That's the kind of trial I first asked for."

Text Continues Below

---

The results of that study will not arrive for at least four or five years, however. In the meantime, the debate over Natrecor continues.

More information

For more on heart failure, visit the American Heart Association.

Page:  << Prev | 1 | 2 | 3 | 4